Case scenario: Management of trauma-induced coagulopathy in a severe blunt trauma patient

Anesthesiology

Volumn 119, Issue 1, 2013, Pages 191-200

  David, Jean Stephane ^a   Godier, Anne ^b   Dargaud, Yesim ^c,d   Inaba, Kenji ^e  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b Assistance Publique Hôpitaux de Paris ^*  (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d UNIVERSITÉ LYON 1   (France)

^e LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETOMIDATE; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; HETASTARCH; INFUSION FLUID; MIDAZOLAM; NORADRENALIN; PROTHROMBIN COMPLEX; SUFENTANIL; SUXAMETHONIUM; TRANEXAMIC ACID;

ADULT; AORTA ARCH; AORTA RUPTURE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; BLUNT TRAUMA; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTRAST MEDIUM EXTRAVASATION; ERYTHROCYTE CONCENTRATE; FEMUR FRACTURE; GENERAL ANESTHESIA; HEMATOTHORAX; HUMAN; HUMERUS FRACTURE; KIDNEY INJURY; LABORATORY DIAGNOSIS; LUNG CONTUSION; MALE; MULTIPLE ORGAN FAILURE; PELVIS FRACTURE; PLATE FIXATION; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; TRANSFUSION RELATED ACUTE LUNG INJURY; TRAUMA INDUCED COAGULOPATHY; WRIST FRACTURE; X RAY;

ACCIDENTS, TRAFFIC; ADULT; ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION DISORDERS; EARLY DIAGNOSIS; FACTOR VIIA; FRACTURE FIXATION; HEMODYNAMICS; HUMANS; MALE; MOTORCYCLES; MULTIPLE TRAUMA; PLASMA; PLATELET TRANSFUSION; POINT-OF-CARE SYSTEMS; THROMBELASTOGRAPHY; TRANEXAMIC ACID; WOUNDS, NONPENETRATING;

EID: 84883245219     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31828fc627     Document Type: Article

References (60)

1. Gruen RL, Brohi K, Schreiber M, Balogh ZJ, Pitt V, Narayan M, Maier RV: Haemorrhage control in severely injured patients. Lancet 2012; 380:1099-108
2. Davenport R, Khan S: Management of major trauma haemorrhage: Treatment priorities and controversies. Br J Haematol 2011; 155:537-48
3. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Stahel PF, Vincent JL, Spahn DR; Task Force for Advanced Bleeding Care in Trauma: Management of bleeding following major trauma: An updated European guideline. Crit Care 2010; 14:R52
4. Theusinger OM, Madjdpour C, Spahn DR: Resuscitation and transfusion management in trauma patients: Emerging concepts. Curr Opin Crit Care 2012; 18:661-70
5. Murad MH, Stubbs JR, Gandhi MJ, Wang AT, Paul A, Erwin PJ, Montori VM, Roback JD: The effect of plasma transfusion on morbidity and mortality: A systematic review and metaanalysis. Transfusion 2010; 50:1370-83
6. Nascimento B, Callum J, Rubenfeld G, Neto JB, Lin Y, Rizoli S: Clinical review: Fresh frozen plasma in massive bleedings- more questions than answers. Crit Care 2010; 14:202
7. Watson GA, Sperry JL, Rosengart MR, Minei JP, Harbrecht BG, Moore EE, Cuschieri J, Maier RV, Billiar TR, Peitzman AB; Inflammation and Host Response to Injury Investigators: Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009; 67:221-7
8. Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, El Attal R, Strasak A, Mittermayr M: The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013; 44:209-16
9. Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C: Goaldirected coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14:R55
10. Schöchl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, Arndt C, Hanke A, Voelckel W, Solomon C: Transfusion in trauma: Thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15:R83
11. Bolliger D, Görlinger K, Tanaka KA: Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthes iology 2010; 113:1205-19
12. Davenport R, Manson J, De'Ath H, Platton S, Coates A, Allard S, Hart D, Pearse R, Pasi KJ, MacCallum P, Stanworth S, Brohi K: Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39:2652-8
13. Frith D, Goslings JC, Gaarder C, Maegele M, Cohen MJ, Allard S, Johansson PI, Stanworth S, Thiemermann C, Brohi K: Definition and drivers of acute traumatic coagulopathy: Clinical and experimental investigations. J Thromb Haemost 2010; 8:1919-25
14. Schols SE, Heemskerk JW, van Pampus EC: Correction of coagulation in dilutional coagulopathy: Use of kinetic and capacitive coagulation assays to improve hemostasis. Transfus Med Rev 2010; 24:44-52
15. David JS, Levrat A, Inaba K, Macabeo C, Rugeri L, Fontaine O, Cheron A, Piriou V: Utility of a point-of-care device for rapid determination of prothrombin time in trauma patients: A preliminary study. J Trauma Acute Care Surg 2012; 72:703-7
16. Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, Gros A, Allaouchiche B, Negrier C: Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007; 5:289-95
17. Cotton BA, Faz G, Hatch QM, Radwan ZA, Podbielski J, Wade C, Kozar RA, Holcomb JB: Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission. J Trauma 2011; 71:407-14
18. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, Stanworth S, Brohi K: Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10:1342-51
19. Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS: Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008; 100:792-7
20. Larsen OH, Fenger-Eriksen C, Christiansen K, Ingerslev J, Sørensen B: Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents. Anesthes iology 2011; 115:294-302
21. Holcomb JB, Zarzabal LA, Michalek JE, Kozar RA, Spinella PC, Perkins JG, Matijevic N, Dong JF, Pati S, Wade CE, Holcomb JB, Wade CE, Cotton BA, Kozar RA, Brasel KJ, Vercruysse GA, MacLeod JB, Dutton RP, Hess JR, Duchesne JC, McSwain NE, Muskat PC, Johannigamn JA, Cryer HM, Tillou A, Cohen MJ, Pittet JF, Knudson P, DeMoya MA, Schreiber MA, Tieu BH, Brundage SI, Napolitano LM, Brunsvold ME, Sihler KC, Beilman GJ, Peitzman AB, Zenati MS, Sperry JL, Alarcon LH, Croce MA, Minei JP, Steward RM, Cohn SM, Michalek JE, Bulger EM, Nunez TC, Ivatury RR, Meredith JW, Miller PR, Pomper GJ, Marin B; Trauma Outcomes Group: Increased platelet: RBC ratios are associated with improved survival after massive transfusion. J Trauma 2011; 71(2 suppl 3):S318-28
22. Brown JB, Cohen MJ, Minei JP, Maier RV, West MA, Billiar TR, Peitzman AB, Moore EE, Cushieri J, Sperry JL; Inflammation and Host Response to Injury Investigators: Debunking the survival bias myth: Characterization of mortality during the initial 24 hours for patients requiring massive transfusion. J Trauma Acute Care Surg 2012; 73:358-64
23. Levi M, Fries D, Gombotz H, van der Linden P, Nascimento B, Callum JL, Bélisle S, Rizoli S, Hardy JF, Johansson PI, Samama CM, Grottke O, Rossaint R, Henny CP, Goslings JC, Theusinger OM, Spahn DR, Ganter MT, Hess JR, Dutton RP, Scalea TM, Levy JH, Spinella PC, Panzer S, Reesink HW: Prevention and treatment of coagulopathy in patients receiving massive transfusions. Vox Sang 2011; 101:154-74
24. Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brant L, Chapman CE, Davison K, Gerrard R, Gray A, Knowles S, Love EM, Milkins C, McClelland DB, Norfolk DR, Soldan K, Taylor C, Revill J, Williamson LM, Cohen H; SHOT Steering Group: Serious hazards of transfusion: A decade of hemovigilance in the UK. Transfus Med Rev 2006; 20:273-82
25. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, Rickman OB, O'Byrne MM, Evenson LK, Malinchoc M, DeGoey SR, Afessa B, Hubmayr RD, Moore SB: Transfusion-related acute lung injury in the critically ill: Prospective nested case-control study. Am J Respir Crit Care Med 2007; 176:886-91
26. Murthi SB, Dutton RP, Edelman BB, Scalea TM, Hess JR: Transfusion medicine in trauma patients. Expert Rev Hematol 2008; 1:99-109
27. Inaba K, Branco BC, Rhee P, Blackbourne LH, Holcomb JB, Teixeira PG, Shulman I, Nelson J, Demetriades D: Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010; 210:957-65
28. Shanwell A, Andersson TM, Rostgaard K, Edgren G, Hjalgrim H, Norda R, Melbye M, Nyrén O, Reilly M: Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma. Vox Sang 2009; 96:316-23
29. Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, Levrat A, Guillaume C, Marcotte G, Vulliez A, Hautin E, David JS, Négrier C, Allaouchiche B: Early coagulopathy in trauma patients: An on-scene and hospital admission study. Injury 2012; 43:26-32
30. de Biasi AR, Stansbury LG, Dutton RP, Stein DM, Scalea TM, Hess JR: Blood product use in trauma resuscitation: Plasma deficit versus plasma ratio as predictors of mortality in trauma (CME). Transfusion 2011; 51:1925-32
31. Martinaud C, Ausset S, Deshayes AV, Cauet A, Demazeau N, Sailliol A: Use of freeze-dried plasma in French intensive care unit in Afghanistan. J Trauma 2011; 71:1761-4
32. Greer SE, Rhynhart KK, Gupta R, Corwin HL: New developments in massive transfusion in trauma. Curr Opin Anaesthesiol 2010; 23:246-50
33. Fries D, Martini WZ: Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010; 105:116-21
34. Weiss G, Lison S, Glaser M, Herberger S, Johanning K, Strasser T, Huber T, Spannagl M, Heindl B: Observational study of fibrinogen concentrate in massive hemorrhage: Evaluation of a multicenter register. Blood Coagul Fibrinolysis 2011; 22:727-34
35. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tønnesen E, Ingerslev J, Sørensen B: Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: A randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7:795-802
36. Levy JH, Szlam F, Tanaka KA, Sniecienski RM: Fibrinogen and hemostasis: A primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012; 114:261-74
37. Hiippala ST, Myllylä GJ, Vahtera EM: Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81:360-5
38. Nienaber U, Innerhofer P, Westermann I, Schöchl H, Attal R, Breitkopf R, Maegele M: The impact of fresh frozen plasma vs. coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 2011; 42:697-701
39. Kalina U, Bickhard H, Schulte S: Biochemical comparison of seven commercially available prothrombin complex concentrates. Int J Clin Pract 2008; 62:1614-22
40. Dickneite G, Dörr B, Kaspereit F, Tanaka KA: Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model. J Trauma 2010; 68:1151-7
41. Sørensen B, Spahn DR, Innerhofer P, Spannagl M, Rossaint R: Clinical review: Prothrombin complex concentrates-evaluation of safety and thrombogenicity. Crit Care 2011; 15:201
42. Grottke O, Braunschweig T, Spronk HM, Esch S, Rieg AD, van Oerle R, ten Cate H, Fitzner C, Tolba R, Rossaint R: Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood 2011; 118:1943-51
43. Dusel CH, Grundmann C, Eich S, Seitz R, König H: Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates. Blood Coagul Fibrinolysis 2004; 15:405-11
44. Frith D, Davenport R, Brohi K: Acute traumatic coagulopathy. Curr Opin Anaesthesiol 2012; 25:229-34
45. Levy JH: Antifibrinolytic therapy: New data and new concepts. Lancet 2010; 376:3-4
46. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K: Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; CD001886
47. Dadure C, Sauter M, Bringuier S, Bigorre M, Raux O, Rochette A, Canaud N, Capdevila X: Intraoperative tranexamic acid reduces blood transfusion in children undergoing craniosynostosis surgery: A randomized double-blind study. Anesthes iology 2011; 114:856-61
48. Roberts I, Prieto-Merino D, Shakur H, Chalmers I, Nicholl J: Effect of consent rituals on mortality in emergency care research. Lancet 2011; 377:1071-2
49. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebocontrolled trial. Lancet 2010; 376:23-32
50. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ: Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg 2012; 147:113-9
51. Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, Axelsen M, Kluger Y; NovoSeven Trauma Study Group: Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59:8-15
52. Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Olkin I, McDonald KM, Owens DK, Stafford RS: Systematic review: Benefits and harms of in-hospital use of recombinant factor VIIa for offlabel indications. Ann Intern Med 2011; 154:529-40
53. Levi M, Levy JH, Andersen HF, Truloff D: Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010; 363:1791-800
54. Stanworth SJ: The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology Am Soc Hematol Educ Program 2007; 179-86
55. Kazmi RS, Lwaleed BA: New anticoagulants: How to deal with treatment failure and bleeding complications. Br J Clin Pharmacol 2011; 72:593-603
56. Cotton BA, McCarthy JJ, Holcomb JB: Acutely injured patients on dabigatran. N Engl J Med 2011; 365:2039-40
57. Levy JH, Key NS, Azran MS: Novel oral anticoagulants: Implications in the perioperative setting. Anesthes iology 2010; 113:726-45
58. Obeng-Gyasi S, Loor MM, Samotowka MA, Moorman ML: Management of dabigatran-induced anticoagulation in trauma and acute care surgery patients. J Trauma Acute Care Surg 2012; 73:1064-9
59. Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J: Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol 2012; 87(suppl 1):S141-5
60. Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Crackowski JL, Pernod G: Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: A randomised crossover ex vivo study in healthy volunteers. Thromb Haemost 2012; 108:217-24